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ABSTRACT
Ginseng Radix (Panax ginseng) is one of the most commonly
used herbs worldwide for the treatment of inflammation-re-
lated diseases among others, supported by ancient historical
records. Throughout this long history, the large-scale cultiva-
tion of ginseng created an increasing demand for long-term
storage of the harvested plant material, accelerating the de-
velopment of post-harvesting procedures. Dried white gin-
seng and processed (steamed) red ginseng are the products
of the two most common traditional post-harvest processes.
Although there are a significant number of reports on prac-
tice-based therapeutic applications of ginseng, science-based
evidence is needed to support these uses. Using a reverse
pharmacology approach in conjunction with high-throughput
techniques and animal models may offer clear, simple paths
for the elucidation of the mechanisms of activity of herbal
medicines. Moreover, it could provide a new and more effi-
cient method for the discovery of potential drug candidates.
From this perspective, the different chemical compositions
of white ginseng and red ginseng could very likely result in dif-
ferent interactions with signaling pathways of diverse biolog-
ical responses. This paper provides an overview of white gin-
seng and red ginseng, mainly focusing on their chemical pro-
file and immunomodulation activities. Synergistic effects of
ginseng herbal drugs with combinations of other traditional
herbal drugs or with synthetic drugs were reviewed. The use
of the zebrafish model for bioactivity testing greatly improves
the prospects for future ginseng research.
The Difference between White and Red Ginseng:
Variations in Ginsenosides and Immunomodulation*
* Dedicated to Professor Dr. Robert Verpoorte in recognition of his out-
standing contribution to natural product research.
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Introduction
Ginseng Radix (Panax ginseng C.A. Meyer, Araliaceae) is one of the
most widely used medicinal herbs in the world, particularly in the
Far East, China, Japan, and Korea. The most frequently used part
of this plant for traditional therapeutic applications is the root
(rhizome and/or radix). Ginseng has a long history of traditional
applications, with records of its medicinal use as an adaptogen,
for the restoration, repair, or healing of the human body, or pre-
vention of disease. Both market demand and academic research
have increased significantly in recent years, while its efficacy has
been disputed in many cases. One of the potentially most impor-
tant reasons for these controversies might lie in the absence of aHe M et al. The Difference between… Planta Med 2018; 84: 845–854correct differentiation of two types of processed ginseng mate-
rial. Besides that, other critical factors such as the geographical
origin, development stage or age, storage, type of extract, among
others, may also contribute to variations in the results. In this
manuscript we focus on the two traditional ginseng preparations
that are mainly used nowadays, i.e., white ginseng (WG) and red
ginseng (RG). After searching the databases Pubmed/MEDLINE,
Embase, and Biosis (for English papers) as well as CNKI (for Chi-
nese papers), with the key words “ginseng” or “white/unpro-845
▶ Fig. 1 Historical development and uses of white/red ginseng in China. Stage 1: The earliest records of therapeutic applications of wild ginseng
can be found in a Chinese ancient book, Shen-Nongʼs Classic of Materia Medica (also known as “Shen-Nung Pen-Tsʼao Ching“ or “Shin-Nong-Bon-
Cho-Kyung”, in Chinese: “Shen-Nong bencao jing”). The texts were compiled during the Han Dynasty (206 BC–220 AD) and were considered to be a
documentation of Shen-Nong who lived around 2800 BC [2]. Stage 2: With a period of enlarged demands, the emergence of ginseng planting/
cultivation began at the end of the Jin Dynasty (~ 300 AD), as mentioned in an ancient Chinese history book “Book of Jin–Shi Le Part” (texts com-
piled and re-edited during the Tang dynasty around 648 AD). Stage 3: During the Tang Dynasty (618–907), ginseng was characterized by a flour-
ishing of indications for different therapeutic purposes and with multi-formulations in Beiji Qianjin yaofang (Invaluable prescriptions, finished in
652 AD); this was later transmitted to Japan, Korea, and other Asian countries. In addition, ginseng was recorded as a plant in the “Materia Medica”,
the first Chinese pharmacopoeia (newly revised canon of Materia Medica; in Chinese: Xinxiu Bencao) published in 659 AD by the Chinese officials.
Stage 4: The earliest record of processed ginseng corresponds to the Song Dynasty (960–1279 AD) [3]. Stage 5: The cultivation, processing, and
applications of ginseng were detailed in Compendium of Materia Medica (in Chinese: Bencao gangmu), which was written by Shizhen Li in the Ming
Dynasty (1368 ~ 1644 AD) and is considered to be the most important source of Chinese herbal medicine for the modern Chinese pharmacopoeia.
Stage 6: This is the current developing stage of official individual monographs of WG and RG in the CP 2015. The differences between WG and RG in
functional characters and therapeutic applications as well as their similar applications such as their benefits for blood nourishing and weakness (lack
of energy) are recorded in detail [4].
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l.cessed ginseng” or “red/processed/steamed ginseng” or “ginse-
nosides”, along with “immune” or “immunomodulation”, there
were approximately 3400 papers (349 in English and 3209 in Chi-
nese) that have been published since the 1980s. Within these pa-
pers, 267 were about P. ginseng C.A. Meyer extracts (35 in English
and 242 in Chinese) and ginsenosides from ginseng (105 in Eng-
lish and 278 in Chinese) under the topic of immunomodulation
against cancer or inflammation. Based on the information from
the literature, both types of ginseng, WG and RG, possess differ-
ent chemical components that could result in different therapeu-
tic activities, especially in cases such as the modulation of the im-
mune system. This paper presents a review of the comparative
studies of WG and RG, focusing mainly on their composition and
efficacy.Historical Development of
White and Red Ginseng
P. ginseng C.A. Meyer has many synonyms, such as Ren shen,
Mountain Ginseng, Korean Ginseng, or Asian ginseng. The name
“ginseng” is also used for many other plants, such as American
ginseng (Panax quinquefolius L., in Chinese: Xiyangshen), Noto
(pseudo) ginseng [Panax notoginseng (Burk) F.H. Chen, in Chinese:
Sanchi/Sanqi], and Japanese ginseng [Panax japonicus, (T. Nees.)
C.A. Meyer], but P. ginseng C.A. Meyer is the still most commonly
used species [1]. The historical development of ginseng as a me-846dicinal plant can be summarized in six major stages (▶ Fig. 1):
Stage 1, 206 BC-220 AD: The earliest records of therapeutic appli-
cations of wild ginseng date back to this period; Stage 2, ~ 300 AD
was characterized by an increase in the demand and consequent
emergence of planting and cultivation; Stage 3, 618–907, during
this time the indications for its use were extended, and multi-for-
mulas were created having been included in the official Materia
Medica; Stage 4, 960–1279 AD witnessed the emergency of gin-
seng processing, accelerated by the increased demand of indica-
tions and the need for long-term storage of harvested material;
Stage 5, 1368 ~ 1644 AD marked the appearance of the official
standard protocol of ginseng processing and applications; and
Stage 6, now is the current developing stage in which separate
monographs of WG and RG have been included in the Chinese
Pharmacopoeia (CP 2015) [2], the Korean Pharmacopoeia [3],
and the Japanese Pharmacopoeia [4].
As summarized above, throughout thousands of years, gin-
seng evolved from a wild herb to being the product of large scale
plantations, requiring the development of post-harvesting and
long-term storage methods to prevent its degradation due to in-
sects, moulds, and fungi. Most of the herbs used in traditional Chi-
nese medicine must be submitted to some type of post-harvest-
ing processing. This processing is not only directed at ensuring a
better stability during storage, but may have other purposes ac-
cording to the herb, such as achieving consistent quality and bet-
ter efficacy, reducing toxic or undesired side effects, modifying
the chemical composition to increase solubility, the removal ofHe M et al. The Difference between… Planta Med 2018; 84: 845–854
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drug material with completely different therapeutic properties to
the original raw material [5]. The simplest post-harvesting proce-
dure is the dehydration of the material by drying in the sun (natu-
rally under sunshine). In the case of ginseng, the result of this
treatment is WG (dried ginseng/unprocessed ginseng, Chinese:
Bai shen). This traditional procedure may not always guarantee
the long-term storage of plant material due to climatic variations
and transportation times. Thus, over time, a number of alternative
processing procedures appeared, such as steaming with or with-
out additional excipients (e.g., alcohol or honey), boiling, and
stir-frying. Among these, the most common process is steaming
the ginseng as following: after harvest ginseng, the side roots of
ginseng will be removed and washed in clean water, then the
cleaned ginseng will be steamed (100°C) for 2–3 h until the roots
color becomes yellow. Then heat-dry or sun-dry the steamed gin-
seng [5]. This procedure can be repeated for several cycles. When
the steaming is done at a high temperature for sterilization, fol-
lowed by drying, a Maillard reaction [6] occurs and the ginseng
acquires a reddish or brown tinge that gives the material the
name red ginseng (RG, processed ginseng/steamed ginseng; in
Chinese: Hong shen/Hongsam). The longer the steaming, the
darker the resulting color of the ginseng. Black ginseng is in fact
the product of a 9-cycle steaming process. However, WG and RG
are the two traditional preparations that are most commonly
used.
Red ginseng was originally developed with the only purpose of
improving the preservation of ginseng for long-term storage.
However, as has been observed in general for most plant material,
the difference in post-harvest treatments can result in changes in
the chemical composition and biological activities of the material
[7]. This proved to be the case for ginseng also. Chinese herbal
medicines are traditionally classified according to the sensations
they evoke in the patient and the patientʼs response, resulting in
descriptive characterizations such as taste, warm/cold, and toxic/
nontoxic. Such classifications have now been scientifically validat-
ed [8, 9]. Based on this theory, both WG and RG are considered to
have “warm” functional characters, but this property may be en-
hanced by the processing of RG [10,11]. While WG is traditionally
considered relatively mild and has the specific function of quench-
ing thirst (one of the main symptoms of diabetes in ancient de-
scriptions), it is also beneficial for the treatment of insomnia and
pulmonary disease. RG is more suitable for weakness in aging pa-
tients, for syndromes of excessive bleeding during puerperium, or
postsurgical weakness. These very different functional characters
of WG and RG and their resulting therapeutic applications are also
recognized in the CP 2015 to the extent that there are now two
separate monographs for WG and RG, reflecting their differences
in therapeutic indications. However, according to the CP 2015 [2],
WG and RG share some similar applications such as their benefits
for blood nourishing and fatigue (lack of energy) [2]. There is,
however, a need for much more scientific evidence to support
the different therapeutic applications that are proposed, as well
as an explanation of the mechanisms of their purported pharma-
cological activities. Nonetheless, when searching for justifications
for the inconsistency in results of pharmacological or clinical stud-
ies with ginseng, it is important to consider that many scientificHe M et al. The Difference between… Planta Med 2018; 84: 845–854researchers may have been unaware of the existence of these
two processed forms of ginseng, and published results actually
correspond to different materials. This could account for the var-
iation of the scientific results reported so far. We thus considered
that it was very important to provide information that could con-
tribute to distinguish these two forms of ginseng, creating aware-
ness of the importance of their differences.Differences in Chemical Composition
of White Ginseng and Red Ginseng
Ginseng saponins, or ginsenosides, are the major active principles
of ginseng. They are triterpenoidal glycosides with a high chemi-
cal variation, depending on the linkage position and number of
sugars on the aglycone skeleton. In general, based on the struc-
ture of aglycone, ginsenosides can be classified into three differ-
ent types: 1) dammarane type, that includes protopanaxadiols
(PPDs) with sugar substituted on C-3, C-20, or both positions,
such as Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rh2, and compound K; and pro-
topanaxatriols (PPTs) with sugar substitutes on C-6, C-20, or both
positions, such as Re, Rf, Rg1, Rg2, and Rh1); 2) oleanane (olea-
nolic acid) type, such as Ro and polyacetyleneginsenoside Ro;
and c) ocotillol type, such as majonosides R1, majonosides R2,
vina-R1, vina-R2, vina-R6, vina-R14, 24-pseudoginsenoside RT4,
and pseudoginsenoside F11 [12–15]. These ginsenosides can be
interconverted (▶ Fig. 2). In P. ginseng C.A. Meyer, only dammar-
ane-type (both PPD and PPT type) and oleanane-type ginseno-
sides are detectable, while the ocotillol type exist mainly in the
P. quinquefolius L. To date, more than 50 different ginsenosides
have been identified in ginseng [16–19]. The content of ginseno-
sides in ginseng varies according to the growth/harvest location,
harvest season, age, and part of the plant [18–28].
Many chemical reactions can occur during the processing (es-
pecially when submitted to heat), and these structural conver-
sions of ginsenosides lead to the main differences between RG
and WG. The structural conversions depend both on the temper-
ature used and the duration of the process. The relative differ-
ences in the ginsenoside content of WG and RG are displayed in
▶ Table 1. In general, PPD-type ginsenosides (Rb2, Rb3, Rc, Rd,
Re1, F2, Ro) as well as PPT-type ginsenosides (Re, Rf, Rg1, Noto-
R1) are relatively more abundant in WG [26]. Conversely, ginseno-
sides (20S- and 20R-) Rg3, Rh1, and Rh2 are considered to be
characteristic components of RG [29,30]. Higher levels of PPD-
type ginsenosides (Ra1, Ra2 and Ra3, Rb1) and PPT-type ginseno-
sides (Rg4) are also found in RG [26]. In WG, malonyl ginsenosides
mRa1/Ra2, mRa3, mRb1, mRb2, mRb3, mRc, mRd, mRe, and
mRg1 are considered to be characteristic components that are
decreased by processing [26,31, 32]. The ginsenoside 20S-Rg2 is
relatively higher in WG, while 20R-Rg2 is higher in RG [26]. Many
acetylated ginsenosides (quinquenoside R1 and ginsenosides Rs1
and Rs2) are relatively abundant in RG because of the inactivation
of the deacetylating enzyme with steaming [30,33]. In addition,
contents of the less polar ginsenosides (F4, F5, Rk1, Rg2, Rg5,
Rg6, 20R-Rs3, 20S-Rs3, and Rs4) are observed in RG because of
their bioconversions during processing at high temperatures
[34–37]. It was also reported that the bioaccessibility of WG and847
▶ Fig. 2 Chemical structures of ginsenosides and their interconversions. Conversion pathways are summarized based on references [16,29–32].
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l.RG may be different [38]. Therefore, not only the differences in
qualitative composition, but also differences in quantitative bio-
availability and qualitative bioconversion should be considered
when further studying the pharmacological differences between
WG and RG.
Apart from ginsenosides, polysaccharides are another class of
important active components in ginseng. The concentration of re-
ducing sugars (acidic polysaccharides) detected in RG are higher
than in WG due to the degradation of sugar components during
processing [39,40]. Maltol and its glucosides have been consid-
ered artificially synthesized products because of the Maillard reac-
tion in the processing of RG [41]. On the other hand, the total lev-
el of phenolic acids and insoluble-bound phenolic acids are rela-
tively higher in WG, while trans-ferulic acid and esterified phenolic
acids are higher in RG [42]. The volatile flavor compounds 2-fu-
ranmethanol and 3-hydroxy-2-methyl-4H-pyran-4-one are con-
sidered to be the major characteristic components of WG, while848RG contains 1,2-benzenedicarboxylic acid dibutyl-ester and 2-fu-
ranmethanol instead [43]. Alkaloids have also been detected in
both types of ginseng.Pharmacology: Immunomodulation
Among the many bioactivities of ginseng reported in the litera-
ture, in this review we have focused on immunomodulation.
There are a number of reasons for our choice. In the first place,
the traditional indications of ginseng as an adaptogenic comprise
activities directed mainly at nourishing, strengthening, or restora-
tion of the homeostasis of the body after a long illness or due to
aging. From a modern perspective, these activities are related to
regulations of the immune system [44]. Secondly, based on scien-
tific research, ginseng has multiple biological bioactivities, such as
vasorelaxation (angio-modulation), but it also has antioxidant,
anti-inflammatory, anticancer, and antidiabetic-related (for obe-He M et al. The Difference between… Planta Med 2018; 84: 845–854
▶ Table 1 Relative content of ginsenosides in WG and RG based on literature studies (references [26,33–41]).
PPD-type WG RG PPT-type WG RG Malonyl
ginsenosides
WG RG Other transformed
ginsenosides
WG RG
Ra1 + ++ Rg4 + ++ mRb1 ++ + Quinquenoside R1 N/A +
Ra2 + ++ Rg4 + ++ mRb2 ++ + Rs1 N/A +
Ra3 + ++ Rh1 + ++ mRc ++ + Rs2 N/A +
Rb1 + ++ Re ++ + mRd ++ + Rk1 – ++
Rg3 + ++ Rf ++ + mRe ++ + 20R‑Rg2 – ++
Rh2 + ++ Rg1 ++ + mRg1 ++ + Rg5 – ++
Rb2 ++ + Noto-R1 ++ + mRa1/mRa2 ++ + Rg6 – ++
Rb3 ++ + 20S‑Rg2 ++ + mRa3 ++ + Rs3 – ++
Rc ++ + Rs4 – ++
Rd ++ + F4 + ++
Re1 ++ + F5 + ++
F2 ++ +
Ro ++ +
–: Not detected; N/A: not reported; +: detected with relatively lower concentration; ++: detected with relatively higher concentration
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l.sity) properties. All these biological effects are closely connected
to inflammation and the immune system. Lastly, the structures of
the terpenoid saponins currently reported have some similarities
to steroids, which play a role in the anti-inflammatory effects or
the modulation of the immune system [45–49]. The partial over-
lapping of the chemical composition of WG and RG suggests that
while they may have some similar biological activities, they also
have many differences. These differences in immunomodulatory
activities should be more exhaustively evaluated since they could
be exploited for better personalized applications and treatments,
and also eventually lead to the discovery of new active molecules
or treatment strategies.
The vast majority of published reports do not specify whether
the investigations were done with WG or RG. We thus selected lit-
erature data related to immunomodulation (▶ Table 2). In this
summary, it is clear that some studies reported effects consistent
with potential immunoactivation, while others pointed towards
immunosuppression. Could these differences be explained by the
use of different ginseng materials (RG/WG) and/or a variation of
the content/ratio of ginsenosides? It has been reported, for exam-
ple, that variations in the ratio of Rg1/Rb1 can lead to an opposing
effect on angiogenesis [50]. As mentioned, the post-harvest pro-
cessing can alter the ratio of various ginsenosides. Other possible
explanations could be totally unrelated to the processing method,
lying rather in differences in the biological responses when using
different cell-based assay systems. Therefore, in vivo assays should
be favored since they are more reliable for the validation of phar-
macological effects.
The significant differences in the relative content of certain
ginsenosides (▶ Table 2) in RG and WG could provide an opportu-
nity to analyze the biological effects of different ginsenosides con-
tained in them. In ▶ Fig. 3, we summarized the cross-talking of
the immunomodulatory effects of ginsenosides classified by their
relative concentration in WG and RG. This data is based on litera-He M et al. The Difference between… Planta Med 2018; 84: 845–854ture information, including enzymes, genes, proteins, and inflam-
matory-based factors. This summary focuses mainly on antioxi-
dant capacity, anti-inflammatory, anticancer activity, and angio-
genesis, as well as their detailed potential pathways (▶ Fig. 3)
[14]. As there are significant differences in the ratio and content
of various ginsenosides (▶ Table 1), the integrated systems view
may reveal some differences in targets and effects of WG and RG
(▶ Fig. 3).
In particular, in the field of inflammation, most studies have fo-
cused mainly on the anti-inflammatory activities of the individual
ginsenosides Rb1, Rh1, Rg1, Rg5, and Re [51]. The mechanisms of
action that have been revealed include the inhibition of enzyme
expression (such as cyclooxygenase) and the production of pro-
inflammatory chemokines, cytokines, prostaglandins, and inter-
leukins [44]. Among these ginsenosides, Rg1 and Re are more
abundant in WG, while the rest are all relatively more abundant
in RG. This may explain the fact that both WG and RG have poten-
tial anti-inflammatory activities that relate to immunomodula-
tion. The significantly greater anti-inflammatory effects exhibited
by RGmight be due to their higher inhibitory effect on the synthe-
sis of NO and IL-6, but also of more inflammatory-related path-
ways/mediators such as NF-κB, TLR, MyD88, IgE level, and their
radical scavenging capacity [34,52–57]. The relationship be-
tween angio-modulation, inflammation, and the immune system
has been well established. Pharmacological studies of ginseng on
angio-modulation refer mainly to ginsenosides Rb1, Rg1, Rg3, Re,
Rd, and Rh1. The mechanisms that have been described involve
the activation of nitric oxide (NO) production to reduce reactive
oxygen species (ROS) production, as well as the activation of
PI3K, AKT/PKB, and the β-catenin/T cell factor-dependent path-
way via the glucocorticoid receptor (GR) [49,58,59]. In the field
of cancer research, a great number of studies have shown the
anticancer effects of ginseng or different ginsenosides, though
to date no comparison between the anticancer effects of WG849
▶ Table 2 Multiple immunomodulation pathways of ginseng extract/pure ginsenosides (no distinction of WR/RG is made).
Ginseng
extract/
ginsenoside
Reported activation of factors related
with immunomodulation
Ref. Reported suppression of factors related
with immunomodulation
Ref.
Ginseng extract
(including gin-
senosides)
Stimulate proliferation of macrophages; enhance
production of IL-12 (both in mRNA and protein lev-
els) via the Th1 response; enhance immunoglobulin
IgM, IgG, and IgA, and IL-2, IFN-γ, IL-4, IL-10 levels;
activation of TLR-4
[53–58]
increases endocytosis of dendritic cells Inhibits maturation of dendritic cells; inhibits expression
of CD-40, CD86, HLA‑DR, and CD1a; inhibition on pro-
duction of IL-12 in dendritic cells
[59]
Increase innatural killer cell activity [57,60,61]
Inhibits expression of CD-40, CD86, HLA‑DR, and CD1a;
decrease of T-lymphocytes CD3+, CD4+8−, CD4−8+
[57,59]
Polysaccharides Enhances proliferation of T and B cells; activation of
macrophages to produce NO, H2O2, IL-1b, RNF‑a,
IL-6, TNF-α, IL-12, IL-17 and IFN-γ; activation of
NF-κB pathways (NF-κB-p65 expression); increases
phagocytic activity of macrophages
[62–69] Inhibits expression of TNF-α, IL-1b, IL-6, IL-12, IFN-
gamma, IL-18, interferon-gamma, and TLR2, TLR4,
TLR9, MyD88, phosphor-JNK‑1/2, phospho-p38 MAPK,
and NF-κB in macrophages
[68,69]
Increases production of IL-12 and TNF-α in
dendritic cells
[67]
Promotes generation of immunosuppressive regulatory
T cells (Tregs)
[70]
Rb1 Enhances serum levels of IL-4 and IL-10 as well as
IFN-γ, IL-2, IL4, TNF-α, IgG1, IgG2a, and IgG2b
[71] Inhibition of TNF-α [72]
Rd Enhances expression of IgG, IgG1, and IgG2b, IL-2,
IFN-γ, IL4, and IL-10
[73]
Rh2 Inhibition of NO production [74]
Compound K Enhances nuclear protein binding to CRE [75] Inhibits production/expression of iNOS, ROS, IL-1, IL-6,
MCP-1, mmp-3 andmmp-9 via MAPK, NF-κB pathways
[75]
Rh1 Inhibits production of NO, ROS, TNF-α; inhibits expression
of NF-κB, IRF-1, STAT1, JAK1, STAT1, STAT3, ERK
[74,76]
Rg1 Increases production of IL-1 by macrophages;
enhances mRNA expression of IL-2 and IL-4;
stimulates VEGF and PI3K/Akt and β-catenin/
T cell factor-dependent pathway via GR
[51,77]
Increases natural killer cell activity [77]
Enhances proliferation of lymphocytes; enhances
IL-2 and IL-4 to induce Th2 in CD4+ T cells
[78,79] Decrease IFN‑r in CD4+ T cells [79]
Rg5 Inhibition of IL-1b and TNF-α, iNOS, and COX-2 in
macrophages
[80]
Re Activation of the insulin signaling pathway via
inhibition of JNK and NF-κB activation and inhibitor
of NF-κB degradation
[81]
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l.and RG has been made [14,60–64]. The antitumor effect of indi-
vidual ginsenosides refers mainly to ginsenosides that are abun-
dant in RG (Rb1, Rg3, Rh1, Rh2, Rg5, and Rs4), and also to some
ginsenosides that are abundant in WG (Rb2, Rc, Rd, Re, Rg1) [14,
26,60,61,65–69]. These results suggest that both WG and RG
may have an anticancer effect, though their mechanisms or path-
ways may differ [70]. Additionally, polysaccharides showed an im-
munostimulatory effect to activate macrophages via the path-
ways of NF-κB and AP-1, as well as ERK, JNK, and TLR2 [71].
Water-soluble ginseng oligosaccharides help with lymphocyte850proliferation [72]. The immunomodulatory and anti-inflamma-
tory effects of ginseng polysaccharides as well as potential path-
ways have been reviewed by Liao et al. [73]. Only one paper com-
pared the effect of polysaccharides from white and red ginseng,
which stated that there was a better effect of red ginseng polysac-
charides against cell death [74].
It is clear that both WG and RG may share biological activities
at a cellular level (▶ Fig. 3). At a human clinical level, however, the
traditional therapeutic indications of these two herbal drugs differ
(CP 2015). Based on the data we collected, we cannot fully justifyHe M et al. The Difference between… Planta Med 2018; 84: 845–854
▶ Fig. 3 Cross-talking of WG and RG. Reported major ginsenosides presented a relatively high content in WG and RG, and their biological activities
are correlated with their relative concentrations present in either WG or RG. Details of the references are in the text.
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l.why and how these two herbal forms have so many multiple bio-
logical effects that overlap in some cases and differ in others. Pos-
sibly, from a systems biology perspective, we can analyze our data
using a reverse pharmacological approach that may provide an
opportunity to reveal and explore “how” and “why” from the
known traditional experience by integrating systems information.
It is also important to consider that all current pharmacological
studies of ginseng focus mainly on a limited number of ginseno-
sides that are available commercially or readily acquired, such as
Rg1, Rb1, Rh1, Rh2, and Rg3, while the vast majority of ginseno-
sides have not been evaluated. Additionally, Cui et al. [75] men-
tioned that the oral bioavailability of ginsenosides is low for proto-
panaxatril and protopanaxadiol in human urine. The other impor-
tant aspect is the role of microflora in the human digestive system
for the bioconversion/metabolism of ginsenosides, as Kong et al.
reported [17]. Therefore, bioavailability is also very important and
may contribute to the bioactivities of WG and RG [38]. A further
comparative study between RG and WG should also be taken into
consideration from this perspective. In short, investigating WG
and RG individually may shed light on the difference in a potential
mechanism(s) that correlates to their therapeutic applications
and characteristic component(s). Furthermore, investigations onHe M et al. The Difference between… Planta Med 2018; 84: 845–854WG and RG may contribute to the development of strategies for
new personalized interventions and the discovery of novel drugs.Interactions of Ginseng with other Drugs
Ginseng is a popular herbal drug that is used worldwide. Thus,
from the consumer safety perspective, it is important that full in-
formation and awareness of the interactions of ginseng with other
herbs andmedicines is readily accessible. According to the ancient
book Shennong bencao jing, ginseng is considered to be a supe-
rior herbal drug with low toxicity. However, based on the records
of Chinese medical applications, the use of ginseng together with
some specific herbs such as Veratrum nigrum L. should be avoided
altogether as it can reduce or even reverse the therapeutic func-
tion of ginseng. Such interactions have recently been supported
by scientific evidence [76]. There are also some other descriptions
of interactions between ginseng and food in Chinese practice, for
instance, the consumption of radish (Raphanus sativus L.) may re-
duce the nourishing effect of ginseng. Further scientific research
focused on these topics is needed to reveal other contraindica-
tions or interactions of ginseng. In addition, some clinical case re-
ports have mentioned the interaction between ginseng with851
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l.some chemical drugs such as warfarin with RG [77] and phenel-
zine [78].
Effect of the Combination of Ginseng Extracts
with other (herbal) Medicines
Few studies related to combinations with ginseng include any ref-
erence to which type, WG or RG, was used for the research. Ac-
cording to Chinese medicinal practice, ginseng can be used alone
or in combination with other herbs. For example, the formula
“Zhu-Xiang”, an herb mixture that contains ginseng and other
herbs such as safflower (Carthamus tinctorius L., Compositae),
has an antitumor effect to inhibit the proliferation of breast can-
cer cells [79]. Not only as an anticancer drug, but also as a drug
against other diseases, ginseng combined with other herbal med-
icines has been reported to have benefits. Gincosan is a famous
mixture of P. ginseng C.A. Meyer and Ginkgo biloba L. extracts that
is frequently used to improve cognitive functions [80]. For in-
stance, it can increase serotonin and decrease noradrenaline levels
in the brain, and increase serum ACTH levels, thus being beneficial
for the brain and improving learning behavior and secondary
memory [81–83]. A combination of a ginseng extract with guara-
na [Paullinia cupana (Mart.) Ducke] has been reported to improve
attention and memory [84]. Dry ginseng extracts with aluminium
hydroxide or mineral oil have been found to synergistically act as
vaccine adjuvants that can enhance immune responses, while Rb1
and Rg1 were observed to act antagonistically and partially inhibit
each other [85,86]. In another case, combination therapy with
ginseng and sodium ozagrel was reported to be more effective
as a neuroprotective for the treatment of transient cerebral ische-
mia since it enhanced neuronal cell survival and inhibited astro-
cytes expansion [87].
Red ginseng acidic polysaccharides, in combination with che-
motherapeutic agents such as cyclophosphamide, pidotimod,
and paclitaxel (taxol), have multiple immunomodulatory effects
as well as antitumor and chemoprotection activities [39,88,89].
The RG acidic polysaccharide in combination with IFN-γ can stim-
ulate macrophage function by increasing the production of IL-1,
IL-6, NO, and TNF-α and activating NF-κB [90,91]. The activation
of SCF and GM‑CSF are also involved in these mechanisms [88]. In
combination with rIL-2, the acidic polysaccharide can also induce
Th1 cell and macrophage cytokines and generate LAK cells [92].
Synergistic Effects of Ginsenoside(s)
with synthetic Pharmaceuticals
The simultaneous administration of Rg3 with docetaxel, paclita-
xel, cisplatin, and doxorubicin showed a synergistic effect against
colon cancer cell growth and apoptosis via inhibition of NF-κB
[93], while its combination with cyclophosphamide exhibited a
synergistic effect against ovarian cancer, prolonging the life of
mice and reducing microvessel density and VEGF levels [94].
Combining Rg3 with gemcitabine or cyclophosphamide was re-
ported to inhibit angiogenesis and growth of lung cancer and im-
prove the survival and quality of life of mice [95,96]. Compound K
in combination with gamma ray radiation was observed to induce
apoptosis, nuclear fragmentation, loss of mitochondrial mem-
brane potential, and activate caspase 3, and enhance regression
of tumor xenografts for cancer therapy [97]. The combination of852Rg1 with Bt2cAMP was reported to synergistically downregulate
the GR by induction of the luciferase reporter gene [46]. Mixtures
of 20-protopanaxatriol with Rg1 or Rb1 acted synergistically,
showing antioxidant activity inducing the Nrf2-antioxidant re-
sponse element [98]. The abundance of Rg1 in WG and Rg3 and
Rb2 in RG may contribute to their antitumor activity, and RG plus
5-fluorouracil has been reported to have a better antiproliferative
effect on human colorectal cancer than the combination of WG
combined with 5-fluorouracil [70]. This difference in antitumor ef-
fect of WG and RGmay reflect different bioresponses. This goes to
prove that it is critical to distinguish which ginseng, WG or RG, is
used in bioactivity studies since the results will provide better
guidance for the clinical applications of ginseng, as well as for
the design of synergistic combinations for cancer treatment and
chemotoxic prevention.Zebrafish as a Model for Research
on the Effect of Red Ginseng and White
Ginseng on Immunomodulation
As can be observed in our summary in ▶ Table 2, different and
even contradictory biological responses have been reported for
ginseng. As mentioned before, the use of different ginseng mate-
rials (RG or WG) or cell-based assay systems could account for
this. Alternatives such as in vivo investigations combined with the
reverse pharmacology approach could provide novel insight into
the biological effects of herbal medicine to obtain more accurate
and consistent results. This requires the use of more advanced
techniques and high-throughput models that provide sufficient
reliable data. Among these, animal models such as zebrafish fulfill
many of these requirements. Zebrafish is a widely used model that
has emerged in recent years for the study of multiple disorders
and is considered to be a rapid and high-throughput drug screen-
ing system [99,100]. According to the strict European and Amer-
ican animal welfare regulations on the protection of animals used
for scientific studies, the zebrafish (particularly the earlier life
stage embryos/larvae) model is considered a replacement or re-
finement method, and has become a popular model for biomedi-
cal and toxicology/pharmacology research. The immune system
of zebrafish is remarkably similar to that of humans, and thus this
animal model is increasingly used to study inflammatory and in-
fectious diseases or other disorders in which the immune system
plays a major role, such as diabetes and cancer [101–103]. Zebra-
fish embryos develop into the larval stage within only 3 days. The
first cells of the immune system appear on the first day after fer-
tilization of the eggs, and within the next 2 days, both macro-
phages and neutrophils are present. The millimetric size of zebra-
fish embryos and larvae makes the experimental conditions eas-
ier, since only low quantities of drugs are needed and administra-
tion through the medium is simple. Macrophages and neutro-
phils, which are the main immune cell types orchestrating the
innate immune response, can be fluorophore-marked using dif-
ferent transgenic lines, such as Tg (mpeg :mcherry) and Tg
(mpx :GFP) [104,105]. Such transgenic models are convenient
for the dynamic visualization of the behavior and interactions ofHe M et al. The Difference between… Planta Med 2018; 84: 845–854
▶ Fig. 4 Recent results of a pilot study on the comparative activity of WG and RG extracts on neutrophil migration using the zebrafish tail-fin am-
putation model. A General scheme of the tail-fin amputation (Amp) zebrafish model with drug treatment. The zebrafish larvae used for this assay
are at 3 days post-fertilization. After 2 h pretreatment with either WG, RG, or beclomethasone (positive control), the larvae tail fin is cut and the
same drug treatment is repeated immediately. At least two time points (2 or 4 h post-amputation) are selected for further microscopic observation
or bioassays. B Schematic figure of the zebrafish larva indicating the position of the tail cut and the areas used for detecting and counting the
neutrophils. C Representative images showing the migration of neutrophils towards the cut edge after tail-fin amputation (4 h post-amputation).
D Preliminary results of the anti-inflammatory activity of WG vs. RG, compared to beclomethasone; the y-axis indicates the number of neutrophils
that migrated to the tail cut edge at 4 h post-amputation.
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l.innate immune cells in a living organism, which is especially useful
for inflammation and cancer studies [106,107].
The zebrafish tail-fin amputation model is a validated inflam-
matory model with visible innate immune system activation (mi-
gration of macrophages and neutrophils) [106]. Such a model is
well suited for studies of ginseng/ginsenoside(s) to visually screen
for anti-inflammatory activity. ▶ Fig. 4 shows an example of pre-
liminary results using this model, suggesting that WG has an
anti-inflammatory effect that is stronger than that of beclome-
thasone, while RG shows no significant effect. Potentially different
mechanisms might be involved, and other indicators of inflamma-
tion, such as the expression of proinflammatory and anti-inflam-
matory genes, level of protein and lipid mediators of inflamma-
tion, and post-translation modification of key enzymes, have yet
to be studied. The potential phagocytic function of macrophages
of ginseng extracts has been evaluated recently using a different
zebrafish model [108].Summary and Conclusions
Current scientific methods for drug discovery and development
include the use of advanced techniques such as genomics, pro-He M et al. The Difference between… Planta Med 2018; 84: 845–854teomics, metabolomics, and combinations of biochemistry, bio-
medicine, computing statistics, and high-throughput assays. De-
spite the success of these in many fields, a shift in paradigm in
the approach to novel drug discovery is urgently needed, and the
reverse pharmacology approach provides a very interesting op-
tion. Natural herbal medicines that have been validated by ancient
wisdom derived from traditional use offer great potential for novel
drug discovery or treatment strategies thanks to their long history
of clinical applications on humans with renown effectiveness but
lack a clear knowledge of the molecular basis for their mecha-
nisms of action. Reverse pharmacology can provide alternative
routes to identify significant candidates and to understand poten-
tial bioactivities, as well as to enhance the efficacy and reduce the
toxicity for advanced treatment strategies [109].
Ginseng is a widely used herb with diverse indications in Asian
countries and its chemical composition and pharmacological ac-
tivities have attracted the attention of researchers in the past dec-
ades. It is rich in many different ginsenosides and polysaccharides,
the content of which may vary both qualitatively and quantita-
tively according to the steaming processing used for post-harvest
treatments. These differences may be beneficial since they can
presumably also have different bioactivities, participating in vari-853
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l.ous signaling pathways related to immunomodulation. The em-
phasis of ginseng studies on efficacy in the future should distin-
guish the material that is being tested, WG or RG, since results
would be more comparable and could provide a more reliable
guide in the search of new active compounds as well as contribute
to the discovery of synergistic effects and their multiple targeting
mechanisms on immunomodulation.
Extending the knowledge of the cellular level to organs and the
human body requires a multilevel approach. This can be achieved
using reverse pharmacology, an emerging approach that has rev-
olutionized the experimental design of studies aimed at discover-
ing potential drugs or treatments and has been applied success-
fully to traditional medicine. Additionally, the need of high-
throughput techniques and animal models is imperative to under-
stand efficacy and the mechanisms of action of component(s)/
combinations. For this, the development of a vertebrate animal
model such as zebrafish has provided a visible, simple way to eval-
uate drug efficacy on immunomodulation, requiring relatively
small amounts of samples that are easily administered. The com-
bination of this pharmacological approach and the availability of
an animal model such as the zebrafish should greatly increase
our understanding of the biological activities of both WG and RG
at an integrated system level.
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